Dan Zandberg
Clinical trials sponsored by Dan Zandberg, explained in plain language.
-
Could common diabetes drugs boost immunotherapy in Hard-to-Treat cancers?
Disease control Recruiting nowThis study is for people with advanced solid tumors like melanoma, lung, liver, or stomach cancer. It tests whether adding metformin or rosiglitazone (diabetes drugs) to standard immunotherapy (anti-PD-1) can improve the body's ability to fight cancer. Participants receive one of…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug timing may boost immune attack on head and neck cancer
Disease control Recruiting nowThis study tests a different way of giving chemotherapy together with the immunotherapy drug pembrolizumab for people with head and neck cancer that has come back or spread. The idea is that giving chemo in short, strong bursts after the immunotherapy might help the immune system…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC